The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Cancer Policy

NIH ends fetal tissue research—again

ACA Marketplace enrollments down by 1.4 million, early data shows

Workforce shortages will threaten access to cancer care, President’s Cancer Panel says in a report

FDA releases 10 guiding principles for AI use in drug development

FDA to increase regulatory flexibility for development of cell and gene therapies

OpenAI launches ChatGPT Health to analyze medical records

Clinical Roundup

Trodelvy + Keytruda show potential as new standard of care in first-line PD-L1+ metastatic TNBC, phase III trial finds

Elenagen DNA-based therapy achieves significant reduction in mortality and increase in OS in PROC

Extracellular vesicles drug delivery mechanism could aid breast cancer treatment, UF study finds

Researchers find cell markers to track TNBC, Baylor College of Medicine study finds

Sylvester-led study focuses on rate of failure in head and neck cancer trials

Researchers develop tool that can identify high- and low-risk metastatic prostate cancer patients earlier

In The Clinic
News Analysis

ACS report trumpets 70% five-year survival for all cancers amid uncertain funding outlook

Health Equity
Trials & Tribulations
Trials & Tribulations

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account